Mitigare
Generic name:colchicine [ KOL-chi-seen ]
Brand names: Colcrys, Mitigare
Drug class:Antigout agents
What is Mitigare?
Mitigare affects the way the body responds to uric acid crystals, which reduces swelling and pain.
Because Mitigare was developed prior to federal regulations requiring FDA review of all marketed drug products, not all uses for this medicine have been approved by the FDA.
The Colcrys brand of colchicine is FDA-approved to treat or prevent gout in adults, and to treat a genetic condition called Familial Mediterranean Fever in adults and children who are at least 4 years old.
The Mitigare brand of colchicine is FDA-approved to prevent gout flares in adults.
Generic forms of colchicine have been used to treat or prevent attacks of gout, or to treat symptoms of Behcets syndrome (such as swelling, redness, warmth, and pain).
Mitigare is not a cure for gouty arthritis or Behcets syndrome, and it will not prevent these diseases from progressing. This medicine should not be used as a routine pain medication for other conditions.
Mitigare may also be used for purposes not listed in this medication guide.
Warnings
Serious drug interactions can occur when certain medicines are used together with Mitigare. Tell each of your healthcare providers about all medicines you use now, and any medicine you start or stop using.
Before taking this medicine
You should not use Mitigare if you are allergic to it.
Some medicines can cause unwanted or dangerous effects when used with Mitigare, especially if you have liver or kidney disease. Your doctor may need to change your treatment plan if you use any of the following drugs:
tipranavir;
itraconazole or ketoconazole; or
HIV or AIDS medicine--atazanavir, darunavir, fosamprenavir, indinavir, lopinavir, nelfinavir, ritonavir, or saquinavir.
To make sure Mitigare is safe for you, tell your doctor if you have:
kidney disease; or
if you ta...